Lee Ainslie's MDLN Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 796,077 shares of Medline Inc. (MDLN) worth $33.44 M, representing 0.36% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Lee Ainslie has initiated a new position in MDLN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Medline (MDLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medline (MDLN) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +796,077 | New Buy | 796,077 | $42.00 |
Lee Ainslie's Medline Investment FAQs
Lee Ainslie first purchased Medline Inc. (MDLN) in Q4 2025, acquiring 796,077 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Medline Inc. (MDLN) for 1 quarters since Q4 2025.
Lee Ainslie's largest addition to Medline Inc. (MDLN) was in Q4 2025, adding 796,077 shares worth $33.44 M.
According to the latest 13F filing for Q4 2025, Lee Ainslie's firm, Maverick Capital LTD, owns 796,077 shares of Medline Inc. (MDLN), valued at approximately $33.44 M.
As of the Q4 2025 filing, Medline Inc. (MDLN) represents approximately 0.36% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Medline Inc. (MDLN) was 796,077 shares, as reported at the end of Q4 2025.